Evaluation of Immune Infiltration Based on Image Plus Helps Predict the Prognosis of Stage III Gastric Cancer Patients with Significantly Different Outcomes in Northeastern China. (25th March 2022)

• Record Type: Journal Article
• Authors: Fang, Tianyi; Wang, Zhidong; Yin, Xin; Wang, Hao; Zhang, Lei; Lin, Xuan; Zhang, Xinghai; Wang, Yimin; Xue, Yingwei
• Other Names: Shi Zhongjie Academic Editor.
• Is Part Of: Disease markers. Volume 2022(2022)
• Publication Date: 2022-03-25
• Subjects: Diagnosis -- Periodicals; Biochemical markers -- Periodicals; Pathology -- Periodicals; 616
• DOI: 10.1155/2022/2893336
• Languages: English
• ISSNs: 0278-0240

Abstract

Abstract : Gastric cancer (GC) might have significantly different outcomes within the same AJCC/UICC-TNM stage. The purpose of this study is to help predict the different prognosis through the pattern of immune cell infiltration. We retrospectively analyzed 2605 patients who underwent radical gastrectomy in the Harbin Medical University Cancer Hospital between 2002 and 2013. For stage III with significantly different survival probability, we analyzed the relationship between immune cell surface antigen and survival in TCGA dataset. Furthermore, 200 cases in stage III GC with different survival outcomes were randomly selected for immunohistochemical verification. Image Plus software was used to evaluate the area of immune cell infiltration. We found that patients in stage III had significantly different outcomes. Bioinformatics analysis showed that there was a significant negative correlation between the expression of immune cell surface antigen and prognosis. In order to investigate whether immune infiltration can distinguish GC patients in stage III with differences in prognosis, we verified by immunohistochemistry that CD4 + T cells, CD20 + B cells, and CD177 + neutrophils infiltrated more in group B with better prognosis; CD8 + T cells, CD68 + macrophages, and CD117 + mast cells infiltrated more in group A with poor prognosis. CD117 + mast cells have the same trend of predicting significance for prognosis in the RNA and protein levels. In conclusion, patients with GC in northeastern China have significant prognostic differences only in stage III. CD117 + mast cells may be important evaluation factors in further studies of Immunoscore.